AIM
NEOS

Assured Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Assured Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,028
Closed -$108K – 1383
2018
Q1 		$108K Buy
+13,028
New +$124K ﹤0.01% 1047

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Assured Investment Management's NEOS Position: Q2 2018 in Review

Assured Investment Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2018, closing a stake of 13,028 shares — an estimated $108K sold.

Assured Investment Management first reported a position in NEOS in Q1 2018 and held it in 1 quarter. The position peaked at $108K in Q1 2018. 73 funds tracked by Wall St. Rank hold NEOS as of Q2 2018.

  • Assured Investment Management reported no remaining Neos Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
  • Assured Investment Management sold 13,028 Neos Therapeutics, Inc shares in Q2 2018, an estimated $108K.
  • Assured Investment Management first reported a position in Neos Therapeutics, Inc in Q1 2018 and held it in 1 quarter.
  • Assured Investment Management's Neos Therapeutics, Inc position peaked at $108K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.